Hamel Associates »

AstraZeneca shares owned by Hamel Associates

Quarter-by-quarter ownership of AstraZeneca shares owned by Hamel Associates from 13F filings

Historical chart of Hamel Associates investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Hamel Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Hamel Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $722k 7.9k 91.93

More positions owned by Hamel Associates

Schwab Strategic Tr Internl Divid (SCHY)
Apple (AAPL)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Exxon Mobil Corporation (XOM)
Ishares Tr TRS FLT RT BD (TFLO)
Chubb (CB)
Bank of New York Mellon Corporation (BK)
Microsoft Corporation (MSFT)
Merck & Co (MRK)
ConocoPhillips (COP)
Procter & Gamble Company (PG)
Illinois Tool Works (ITW)
Chevron Corporation (CVX)

View all positions for Hamel Associates

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Ameriprise Financial
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca